Phase 2 Obesity Trial, Recruiting NCT07359261 Sponsor: University of Alberta Condition: Obesity
Back to Obesity

Phase 2 Obesity Trial, Recruiting

NCT07359261
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • Your body weight falls into the category classified as obese (a BMI of 30 or higher)
  • You are currently on a breathing machine (ventilator) that is doing all the breathing for you
  • You have been on the breathing machine for less than 24 hours at the time of joining
  • You are expected to need the breathing machine for at least 48 hours

Who may not be able to join:

  • You have, or are suspected to have, swollen veins in your food pipe (esophagus)
  • You have had surgery on your food pipe (esophagus) in the last 3 months
  • You have a known narrowing or tear in your food pipe (esophagus)
  • You are actively bleeding in your upper digestive tract (stomach or esophagus area)
  • Your blood does not clot properly, based on specific blood test results (confirm with trial site)
  • You have raised pressure in your skull that is not being safely monitored and controlled (confirm with trial site)
  • Your blood pressure or circulation is severely unstable, as judged by your doctor
  • You are pregnant
  • Your medical team expects you to survive less than 48 hours
  • You are on a life-support machine that circulates blood outside the body (ECMO)
  • Your abdomen has been left open after surgery
  • You have already taken part in this study before
  • Your medical team has identified any other reason why a balloon placed in your food pipe (esophagus) would not be safe for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 780.492.9951

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
5 February 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility of conducting a definitive trial (composite)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov